πŸ‡ΊπŸ‡Έ FDA
Patent

US 11351264

PAR2 mimetic peptides and uses thereof

granted A61KA61K38/00A61K38/177

Quick answer

US patent 11351264 (PAR2 mimetic peptides and uses thereof) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arizona Board of Regents on Behalf of the University of Arizona
Grant date
Tue Jun 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K38/00, A61K38/177, A61K47/542, A61K47/543